technetium has been researched along with tafamidis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, CC; Cheng, MF; Hsieh, ST; Lin, YH; Shun, CT; Su, MY; Tsai, CH; Wu, YA | 1 |
| Izumi, C; Morita, Y; Ohta-Ogo, K; Okada, A; Tateishi, E | 1 |
2 other study(ies) available for technetium and tafamidis
| Article | Year |
|---|---|
Reverse cardiac remodelling and dysfunction in A97S transthyretin cardiac amyloidosis after tafamidis treatment.
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Diphosphates; Heart Failure; Humans; Prealbumin; Technetium; Ventricular Remodeling | 2022 |
Serial
Topics: Amyloid Neuropathies, Familial; Amyloidosis; Cardiomyopathies; Diphosphates; Heart Failure; Humans; Prealbumin; Radionuclide Imaging; Radiopharmaceuticals; Technetium | 2023 |